Investors
EQL Pharma develops, sells and markets medicines with a focus on niche products having no patent protection. The company currently has a smaller portfolio on the market and an extensive pipeline of unique medicines. EQL Pharma strives to maintain an open and proactive dialogue with current and potential shareholders and to give the market and society a good insight into and understanding of our business.
Stock Information
Financial Report
Financial Calendar
Presentations
Offer
2014
Annual Report 2014
2013
Annual Report 2013
2011
Annual Report 2011
2010
Annual Report 2010
2009
Annual Report 2009
2008
Annual Report 2008
2007
Annual Report 2007
Financial Calendar
16
August 2022
- Interim report April - June (Q1)
17
August 2022
- Annual General Meeting 2022, Lund
11
November 2022
- Interim report July - September (Q2)
14
February 2023
- Interim report April - June (Q1)
11
May 2023
- Year-end report January - March (Q4)